Author

Jesus Iraheta

Washington University in St. Louis

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Benjamin A. GarciaiD· 1 shared Cynthia X. MaiD· 1 shared Ian S. HagemanniD· 1 shared Jacob HsiaiD· 1 shared Joanna M. GongoraiD· 1 shared John R. EdwardsiD· 1 shared Julie L. PrioriD· 1 shared Maureen K. HighkiniD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Benjamin A. GarciaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

HER2; p53 Co-mutated Cancers Show Increased Histone Acetylation and are Sensitive to Neratinib plus Trastuzumab Deruxtecan.

Xiaoqing Cheng, Jacob Hsia, Jesus Iraheta, Joanna M. Gongora, Maureen K. Highkin, Xiaohua Jin, Zhanfang Guo, Julie L. Prior, John R. Edwards, Shunqiang Li, Ian S. Hagemann, Cynthia X. Ma, Zongtao Lin, Benjamin A. Garcia, Ron Bose

This study shows that HER2 and TP53 co-mutant cancers have increased histone acetylation and are sensitive to neratinib plus trastuzumab deruxtecan.

bioRxiv · Jul 6, 2025 · PreprintCancer Biology